US Medicare recipients now pay an average of $3,142 a year for servicesnot covered by the program, including prescription drugs, and if no changes are made to the system, this will rise to $5,248 by 2025, estimates the Urban Institute, a Washington-based research group. The average proportion of their income which beneficiaries would pay out of their own pocket would thus rise from one-fifth to one-third, it says, estimating that the Medicare population will grow from about 40 million to 70 million over the period.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze